Skip to main content
OpenTrials
Completed

NCT Number: NCT01868763

TeleLifestyleCoaching for Weight Loss

Lifestyle changes often fail due to loss of motivation. Telemedicine and personal coaching have the potential to support lifestyle change and weight loss. Therefore, the aim of our randomized controlled trial was to examine the effect of telemedicine with and without coaching in comparison to a control group on weight loss in overweight participants.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

West-German Centre of Diabetes and Health

Düsseldorf, 40591, Germany

About this study

In an occupational health care setting overweight employees were randomized into a three arm 12-week trial. Participants in the telemedical (TM) and telemedical coaching (TMC) group got a weighing machine and a step counter, with automatic transfer into a personalized online portal, which could be monitored from both, the participant and the study centre. The TMC group weekly got care calls from the study centre aiming to discuss measured data and to fix target agreements. The control group remained in routine care. Wilcoxon signed rank test was used to determine if differences (baseline vs. after 12 weeks) were significantly different from 0 and ANOVA test for determination of inter group differences.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI ≥27 kg/m2

Exclusion criteria

  • Hypoglycemia inducing medication
  • severe disease with hospital stay during the last 3 months
  • smoking cessation for less then 3 months
  • planned smoking cessation during study phase
  • acute infects
  • chronic diseases

Treatment and study plan

telemedical devices (weighing machine and step counter)

Device

care calls once per week for 12 weeks

Behavioral

Primary outcomes

  1. weight loss

    Time frame: 12 weeks

    Weight will be measured at baseline and after 12 weeks

Secondary outcomes

  1. cardiometabolic risk factors

    Time frame: 12 weeks

    Body mass index [kg/m2], waist circumference [cm], blood pressure [mmHg], triglycerides [mg/dl], HbA1c [%], total, HDL and LDL cholesterol [mg/dl]

Sponsors and collaborators

Lead sponsor

West German Center of Diabetes and Health

Other

Collaborators

  • HMM Holding AG

Registry information

Official study title

TeleLifestyleCoaching Use of Telemedicine for Weight Loss and Care of Weight Associated Illnesses

Acronym: FitMeFit

Important dates

Study start
2012
Primary completion
2012
Study completion
2013
First posted
Jun 5, 2013
Registry last updated
Jun 6, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.